Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
Hematopoietic stem cell transplantation in multiple sclerosis
Acta Neurologica Scandinavica, 09/28/09
Rogojan C et al. – This review is a comprehensive study of the results obtained in several single–center and multicenter studies. Patient characteristics, transplantations steps, toxicity and clinical outcome have been monitored and compared.
Related Articles
Retrospective comparison of mobilization methods for autologous stem cell transplantation in multiple myeloma
American Journal of Hematology, 11/10/09
Relevance Score: 99%
Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysis
Bone Marrow Transplantation, 10/29/09
Relevance Score: 98%
History of cord blood transplantation
Bone Marrow Transplantation, 10/07/09
Relevance Score: 98%
Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD)
Bone Marrow Transplantation, 10/01/09
Relevance Score: 98%
Outcome of hematopoietic cell transplantation in children with sickle cell disease, a single center's experience
Bone Marrow Transplantation, 10/01/09
Relevance Score: 98%
Today in Demyelinating Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
Psychosocial dysfunction in the first year after Guillain-Barré syndrome
Muscle & Nerve, 12/01/09
Multiple sclerosis in a family on the Faroe Islands
Acta Neurologica Scandinavica, 12/01/09
Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: A phase II open label clinical trial
Amyotrophic Lateral Sclerosis, 12/01/09
Sponsor
Article Search
Sponsor


See Latest Articles


